Inhibition of poly(ADP-ribose) polymerase in BRCA mutation carriers.
Li
Shuzhuang
S
D005260:Female; D019398:Genes, BRCA1; D024522:Genes, BRCA2; D006801:Humans; D007109:Immunity / Q000187:drug effects; D008875:Middle Aged; D009154:Mutation; D010051:Ovarian Neoplasms / Q000188:drug therapy / Q000235:genetics; D010793:Phthalazines / Q000009:adverse effects*; D010879:Piperazines / Q000009:adverse effects*; D000067856:Poly(ADP-ribose) Polymerase Inhibitors; D050053:TRPM Cation Channels / Q000187:drug effects* / Q000378:metabolism
D010793:Phthalazines; D010879:Piperazines; D000067856:Poly(ADP-ribose) Polymerase Inhibitors; D050053:TRPM Cation Channels; C121934:TRPM2 protein, human; C531550:olaparib